to different antifungal agents. In vitro, antifungal susceptibility testing could therefore, prove helpful in the better management of the dermatophytosis because effective antifungal agents for the optimisation of antifungal therapy can be selected by this method by determining minimum inhibitory concentrations (MICs) of these agents. Broth macro-and micro-dilution methods, agar dilution and disc diffusion methods are routinely used for this purpose. [4, 5] For determining MICs, Clinical and Laboratory Standards Institute (CLSI) approved protocol M38-A2 for filamentous fungi including dermatophytes has been recommended in its guidelines of 2008. [6] The present study presents the susceptibility patterns of dermatophyte species recovered from superficial mycoses of human patients to itraconazole, terbinafine, and ketoconazole.
Methodology
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Dermatophyte species studied
We have previously isolated dermatophyte species recovered from superficial mycoses from human patients at Solan and Shimla regions of Himachal Pradesh. [1] In the present study of 53 of these isolates (T. mentagrophyte-34, T. rubrum-18 and Microsporum gypseum-1) have been tested for the susceptibility to itraconazole, terbinafine, and ketoconazole. The isolates were maintained in sterile distilled water and cultured on potato dextrose agar (PDA) medium at 30°C for 5-7 days before subjecting them to susceptibility testing. Candida parapsilosis strain ATCC-22019 and Candida krusei strain ATCC-6258 were included as reference strains in the test.
Antifungal agents
Three antifungal drugs itraconazole (Metro Chem API Pvt. CTD Erragadda, Hydrabad, India), ketoconazole (Aarti drugs Ltd., Thanne, Maharashtra, India) and terbinafine (Shreeji Pharma International, Sarabhi, Vadodara, Gujarat, India) in powdered form were used in the study.
Determination of antifungal susceptibility testing
Broth microdilution method
Broth microdilution method M38-A2 approved protocol of CLSI (2008) for filamentous fungi was followed for determining the susceptibility of dermatophyte species.
Drug dilutions
Stock dilutions of itraconazole, ketoconazole and terbinafine were prepared in dimethyl sulfoxide (HiMedia) according to the standard protocol. The two-fold dilutions of the stock solution were further prepared in RPMI 1640 medium with L-glutamine and without sodium bicarbonate (HiMedia). These dilutions were used in the test at a pH of 7.0 ± 0.1 with 3-(N-morpholino) propanesulfonic buffer (HiMedia) along with 1N NaOH. The concentrations of different dilutions of the antifungal drugs ranged from 0.0078 μg/ml to 128 μg/ml.
Preparation of inoculums of dermatophyte species
Cultures of dermatophyte species (7-8 days old) grown on PDA slants at 30°C were used to prepare inoculums. The fungal growth was covered with 5 ml of sterile normal saline and suspensions prepared by scraping the growth from the surface of the slants with a sterile swab that contained conidia and hyphal fragments. The heavy particles were allowed to settle down for 10-15 min. The upper clear suspension was transferred to fresh tube, and its optical density was set equal to 0.5 McFarland standards. The final cell density was set between 2 × 10 3 and 6 × 10 3 colony forming units per ml. which was used in the assay.
Test procedure
Flat-bottomed, 96 well microtitre plates (Costar-3596) having 8 rows and 12 columns were used to perform the susceptibility test. Eight test organisms in a volume of 100 μl each was placed in the wells of 8 rows of the plates (one test organism in each row). The dilutions (100 μl) of the drugs were added in the each well of ten columns of the plate from left to right. The concentration of the drug was highest in the first column and decreases from left to right. The contents were incubated at 35°C for 4-5 days. The 11 th and 12 th columns contained inoculated positive controls and un-inoculated negative control respectively.
Quality control reference strains
Candida parapsilosis strain ATCC-22019 and C. krusei strain ATCC-6258 were used as quality control reference strains as approved by the CLSI and their susceptibilities to itraconazole, terbinafine and ketoconzole were also tested. The plate containing these strains was incubated at 28°C for 48 h, as recommended by CLSI.
Determination of minimum inhibitory concentration values
The MIC value of a drug is defined as the lowest antifungal concentration at which no growth is visible in the wells when detected visually (80-100% inhibition) [ Figure 1 ]. These values for each drug were recorded.
Data analysis
The mean values, MIC range, MIC 50 and MIC 90 values were determined for all antifungal agents, used in the assay, as per the standard protocol. The statistical analysis was done by t-test using IBM-SPSS 20 (IBM-International Business Machine. SPSS-Statistical Product and Service Solutions version 20. SPSS Graphical Tools for use with IBMSPSS Statistics and other SPSS products.) software in order to find the independence of the variables or whether they had similarity in their MIC values with P < 0.005.
Results
The MIC ranges, Minimum concentration that inhibited 50% of the isolates (MIC 50 ) and 90% of the isolates (MIC 90 ) and the mean MIC values of the each antifungal drug are shown in Table 1 . In order to illustrate the determination of MIC values, a representative case demonstrating MIC of terbinafine against dermatophyte isolates is presented through Figure 1 .
The MIC range, MIC 50 , MIC 90 and mean values of itraconazole against T. mentagrophyte were 0.0156-1 μg/ml, 0.125 μg/ml, 0.50 μg/ml and 0.2486 μg/ml respectively while the values were 0.0156-1 μg/ml, 0.625 μg/ml, 0.50 μg/ml and 0.1918 μg/ml in case of T. rubrum isolates.
Higher MIC values of antifungal agents have been observed against few dermatophyte species. Three isolates of T. mentagrophytes (VBS-5, VBSo-3 and VBSo-73) and one isolate of T. rubrum (VBPo-9) had higher MIC values of itraconazole (1 μg/ml).
The MIC range, MIC 50 , MIC 90 and mean values of terbinafine against T. mentagrophyte were 0.0625-4 μg/ml, 0.50 μg/ml, 2.0 μg/ml and 0.9319 μg/ml respectively while these values were 0.0313-1 μg/ml, 0.50 μg/ml, 0.2 μg/ml and 0.7378 μg/ml against T. rubrum isolates. As shown in Table 1 , higher MIC values of terbinafine were also observed in eight T. mentagrophyte isolates (VBS-1 = 4 μg/ml; VBS-3, VBSo-5, VBSo-17, VBSo-18, VBSo-39, VBSo-50, M-2 = 2 μg/ml) and two T. rubrum isolates (VBSo-22 = 2 μg/ml, VBPo-9 = 4 μg/ml).
The MIC range, MIC 50 , MIC 90 and mean values of ketoconazole against T. mentagrophyte were 0.0156-2 μg/ml, 0.0625 μg/ml, 0.50 μg/ml and 0.2642 μg/ml while these values were 0.0156-0.5 μg/ml, 0.125 μg/ml, 0.50 μg/ml and 0.1954 μg/ml against T. rubrum isolates. Similarly, the higher MIC values of ketoconazole were observed only in the three isolates of T. mentagrophyte (VBSo-30 = 2 μg/ml; VBSo-44, VBM-2 = 1 μg/ml).
Among the 34 T. mentagrophyte isolates examined in this study, 22.52% (8/34) exhibited MIC values of 0.0625 μg/ml of itraconazole, 20.5% (7/34) isolates had 1 and 2 μg/ml each of terbinafine and 29.41% (10/34) isolates had MIC values of 0.125 μg/ml of ketoconazole. In case of T. rubrum, 33.33% (6/18) isolates exhibited MIC values of 0.0625 μg/ml of itraconazole, 22.22% (4/18) isolates, each of 0.125, 0.5,1 μg/ml of terbinafine and 33.33% (6/18) isolates had MICs of 0.125 μg/ml of ketoconazole.
Only one isolate of M. gypseum (VBM-32) was tested for its susceptibility against antifungal drugs. The MIC values of this isolates were 0.125 μg/ml, 2.0 μg/ml Figure 1 : Determination of minimum inhibitory concentrations (MICs) of terbinafine by micro-broth dilution method against different dermatophyte isolates VBSo-44, VBSo-30, VBS-17, VBS-18 (MIC = 1 μg/ml) VBP-24 (MIC = 0.25 μg/ml), VBP-37 (MIC = 1 μg/ml), VBPo-13 (0.125 μg/ml), VBPo-15 (MIC = 0.5 μg/ml) (A to H rows respectively). The wells 1-10 containing the isolates were treated with two fold dilutions of terbinafine starting from a concentration of 4-0.0156 μg/ml. Eleventh column does not contain terbinafine (abbreviated as C+) and 12 th column is blank (contains medium only, abbreviated as C−) and 0.0625 μg/ml against itraconazole, terbinafine and ketoconazole respectively.
Discussion
Dermatophytosis is the most common superficial mycoses in humans and domestic animals. [7] A number of antifungal agents have been introduced for treating this condition and more are underway. [8] Different dermatophyte strains have different antifungal susceptibility patterns. Strains of dermatophyte resistant to particular antifungal agent have been reported. [9] The introduction of wide range of new antifungal agents and the recovery of clinical isolates exhibiting resistance to antifungal agents such as amphotericin B, azole group etc., makes testing of the susceptibility of dermatophytes to these agents more important particularly for surveillance of resistant strains, in epidemiological studies. It plays an important role in detecting resistant strains that might help clinicians for better management of the disease caused by them by selecting appropriate therapeutic options for checking further spread.
Prior to CLSI guidelines of 2008, there was no definitive system to determine the susceptibility of dermatophytes to different antifungal agents. Due to the lack of suitable and effective methods of determining the in vitro antifungal susceptibility and the MICs of the antifungal drugs against dermatophytosis, it is not possible to ensure effective treatment. A number of techniques have been used for this purpose, e.g., disk diffusion method, broth macro and microdilution method, colorimetric microdilution method, E-test etc. [10] [11] [12] [13] Some researchers followed the protocol M38-A of CLSI 2002 for determining the susceptibility of dermatophytes that was intended for filamentous fungi. [14] Later, the document was modified to M38-A2 by CLSI in 2008. This document also includes the protocol for dermatophytes which has been followed by us for determining the MIC values of itraconazole, terbinafine and ketoconazole against different dermatophyte species. The unavailability of such reference method previously was due to the difficulty in the standardisation of some parameters such as temperature, incubation time, selection of growth medium etc., for different species of dermatophytes. [15] In the present study, we incubated T. rubrum, T. mentagrophyte and M. gypseum at 35°C as mentioned in the M38-A2 protocol. Some researchers have obtained better growth of dermatophyte species at 28°C. [16] [17] [18] For determining the MICs of itraconazole, terbinafine and ketoconazole, the cultures of T. mentagrophyte and M. gypseum were incubated for 4 days and T. rubrum for 5 days as good growth was observed after incubation of specified period. Good inhibitory activity of all the three antifungal agents against T. mentagrophyte, T. rubrum and M. gypseum was demonstrated in the present study [ Table 1 ]. Itraconazole and ketoconazole had the lower mean MIC values as compared to terbinafine. This suggests more effectiveness of both the drugs as compared to terbinafine. Low MIC values for these antifungal agents have also been reported by others. [9, 19] Trichophyton mentagrophyte isolates were found more susceptible to both itraconazole and ketoconazole as compared to terbinafine since lower MIC 50 values of these drugs against T. mentagrophyte (itraconazole-0.125 μg/ml and ketoconazole-0.0625 μg/ml) were observed whereas this value was recorded at 0.5 μg/ml for terbinafine. The values are comparable to those reported by others in respect of T. rubrum and T. mentagrophyte. [20, 21] As no significant difference of MIC 50 values among T. rubrum and T. mentagrophyte isolates was observed by us, both the species exhibited similar susceptibility to terbinafine also. The MIC 50 and MIC 90 values of this drug were recorded at 0.5 μg/ml and 2 μg/ml respectively. These values are higher than those reported by other workers. [14, 22] These results may be linked to the observations of Gupta et al., 1998 and Roberts in 1997 who reported that the oral drug formulations of terbinafine and itraconazole were required in more extensive and severe fungal infections. [23, 24] Ketoconazole was found most effective against a single isolate of M. gypseum tested in the study as compared to other two antifungal agents as reflected by the MIC values. In order to obtain a better picture of susceptibility pattern of M. gypseum, a large number of isolates of this species need to be analysed before making definitive conclusion.
Comparative analysis of the effectiveness of the three antifungal drugs based on t-test revealed that 'itraconazole and terbinafine' and 'terbinafine and ketoconazole' were found independent based on the P < 0.005 in case of T. mentagrophyte isolates. However, the similarity existed between MIC values of 'itraconazole and ketoconazole' against T. mentagrophyte as the P > 0.005 was recorded in this case. In case of T. rubrum, the MIC values of 'itraconazole and terbinafine' were found independent on the P <0.005. However, the similarity existed between MIC values of 'itraconazole and ketoconazole' and 'terbinafine and ketoconazole'. The MIC 50 and MIC 90 observed in the present study based on standard protocol M38-A2 of CLSI 2008 might serve as reference for further studies covering large number of isolates from different geographic regions of the state. Also, such studies might reflect on the acquisition of drug resistance among isolates of dermatophyte species based on MIC values.
